| Prev Close | 45.96 |
| Open | 45.96 |
| Day Low/High | 45.95 / 45.99 |
| 52 Wk Low/High | 22.11 / 46.01 |
| Volume | 9.49M |
| Avg Volume | 4.75M |
Latest News
Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid
Valeant comes out on top, following a competing bid from Endo International for the gastrointestinal drugmaker Salix.
'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head
Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.
Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead
Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.
NPS PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. (NPSP) Over The Proposed Sale Of The Company To Shire PLC
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc.
FDA Approves Natpara® (parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of NPS...
NPSP INVESTOR ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of NPS Pharmaceuticals Inc. In Connection With The Fairness Of The Sale Of The Company To Shire Plc
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of NPS Pharmaceuticals Inc.
NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Of The Board Of Directors Of NPS Pharmaceuticals Inc. Concerning The Fairness Of The Sale Of The Company To Shire Plc
Levi & Korsinsky is investigating the Board of Directors of NPS Pharmaceuticals Inc.
A Tasty Reversal With 6 Key Ingredients
But tomorrow we hear from the banks.
Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR
Cramer remains a big fan of Alcoa and thinks Acorda Therapeutics is exactly what investors should be looking for in a growth stock.
Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses
The restaurants and the biotechs tried their best to save us but it just wasn't enough, Cramer says.
NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of NPS Pharmaceuticals, Inc. Over The Proposed Sale Of The Company To Shire Plc
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc.
Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of NPS Pharmaceuticals, Inc. Stockholders
Kirby McInerney LLP is investigating potential claims against NPS Pharmaceuticals, Inc.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of NPS...
Shire's Takeover of NPS Pharmaceuticals: What Wall Street's Saying
Here's what analysts were saying about Shire's takeover of NPS Pharmaceuticals.
Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices
Oil continues to pressure stock markets on Monday following a price warning from Goldman Sachs analysts.
Jim Cramer Explains Why Shire's Purchase of NPS Pharmaceuticals (NPSP) is Important
TheStreet's Jim Cramer explains why he likes Shire's (SHPG) deal to buy NPS Pharmaceuticals (NPSP) for $5.2 billion in an all-cash transaction.
3 Stocks Moving The Health Care Sector Upward
TheStreet highlights 3 stocks pushing the health care sector higher today.
NPS PHARMACEUTICALS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Shire PLC
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of NPS...
Stocks Are Falling as Oil Prices Crumble to New 5-Year Low
Stocks fall as investors flee energy stocks.
NPSP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches An Investigation Of The Board Of Directors Of NPS Pharmaceuticals Inc. Regarding The Fairness Of The Sale Of The Company To Shire Plc-- NPSP
Levi & Korsinsky is investigating the Board of Directors of NPS Pharmaceuticals Inc.
NPS Pharmaceuticals (NPSP) Stock Spikes Today After Agreeing to Acquisition
NPS Pharmaceuticals (NPSP) shares are climbing after the company agreed to be purchased by Shire plc for $5.2 billion.
EQUITY ALERT: The Rosen Law Firm Announces Investigation Of NPS Pharmaceuticals Concerning Its Proposed Sale To Shire - NPSP
The Rosen Law Firm announces that it is investigating the Board of Directors of NPS Pharmaceuticals, Inc.
Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals
The Dublin company bounces back three months after the collapse of its own $49 billion takeover by AbbVie.
Stock Futures Recover From Friday’s Jobs Growth Jitters
Stock futures rise slightly Monday morning following Friday's volatile session.
Heavy Early Morning Activity On NPS Pharmaceuticals (NPSP)
Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a pre-market mover with heavy volume candidate
January 12 Premarket Briefing: 10 Things You Should Know
U.S. stock futures rise; Shire agrees to buy NPS Pharmaceuticals for $5.2 billion; GM to roll out a $30,000 electric vehicle; Alcoa kicks off fourth-quarter earnings season.